658
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review

, MBBCh, DTM&H, MSc, PhD, , DVM, MPH, , MD, PhD ORCID Icon, , MSc, , FCPaed, MMed, Cert Card(Paed), , MD, MRCP, FRCPath, , FRCPath, MRCP, , PhD, , MD ORCID Icon ORCID Icon, , MBBCh, FCPath(Micro), , MD, , MSc, , FCP (SA), MMed (Wits), Dip HIV Man (SA), , MD, MSc, PhD, , MD, PhD & , MD ORCID Icon show all
Pages 508-517 | Received 31 Jul 2016, Accepted 21 Dec 2016, Published online: 01 Feb 2017

REFERENCES

  • Goodner EK, Okumoto M. Intraocular listeriosis. Am J Ophthalmol. 1967;64(4):682–686.
  • Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: A contemporary reappraisal. Surv Ophthalmol. 1986;31(2):81–101.
  • Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832–838.
  • Palexas GN, Green WR, Goldberg MF, et al. Diagnostic pars plana vitrectomy report of a 21-year retrospective study. Trans Am Ophthalmol Soc. 1995;93:281–308; discussion -14.
  • Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–423.
  • Mimouni M, Geffen N, Rosen E, et al. The effect of gatifloxacin 0.3% or moxifloxacin 0.5% on corneal healing, ocular tolerability and toxicity following pterygium surgery. Cutaneous Ocul Toxicol. 2016;35(1):8–12. DOI:10.3109/15569527.2014.1003266
  • Mahor A, Prajapati SK, Verma A, et al. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation. J Colloid Interface Sci. 2016;483:132–138. DOI:10.1016/j.jcis.2016.08.018
  • Godshall CE, Suh G, Lorber B. Cutaneous listeriosis. J Clin Microbiol. 2013;51(11):3591–3596. DOI:10.1128/JCM.01974-13
  • Potter J, Agrawal R, Barraclough C, et al. Moxifloxacin: An alternative to ethambutol for the treatment of presumed ocular tuberculosis. Ocul Immunol Inflammation. 2016;24(5):508–514. DOI:10.3109/09273948.2015.1019155
  • Clode AB, Davis JL, Salmon J, et al. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. Am J Vet Res. 2010;71(5):564–569. DOI:10.2460/ajvr.71.5.564
  • Bennett JE, Dolin R, Blaser MJ, et al. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th edn. Cambridge, MA: Elsevier Health Sciences; 2014.
  • Nigrin J, Tyrrell DL, Jackson FL, et al. Listeria monocytogenes endophthalmitis in an immune-suppressed host. Can Med Assoc J. 1977;116(12):1378–1382.
  • Eliott D, O’Brien TP, Green WR, et al. Elevated intraocular pressure, pigment dispersion and dark hypopyon in endogenous endophthalmitis from Listeria monocytogenes. Surv Ophthalmol. 1992;37(2):117–124.
  • Lohmann CP, Gabel VP, Heep M, et al. Listeria monocytogenes-induced endogenous endophthalmitis in an otherwise healthy individual: Rapid PCR-diagnosis as the basis for effective treatment. Eur J Ophthalmol. 1999;9(1):53–57.
  • Ibraheem M, Vance S, Jackson KA, et al. Vision loss following intraocular listeriosis associated with contaminated cantaloupe. Case Rep Ophthalmol. 2013;4(2):7–11. DOI:10.1159/000351858
  • Mendez-Hernandez C, Garcia-Feijoo J, Garcia-Sanchez J. Listeria monocytogenes-induced endogenous endophthalmitis: Bioultrasonic findings. Am J Ophthalmol. 2004;137(3):579–581. DOI:10.1016/j.ajo.2003.08.049
  • Alkatan HM, Al-Dhibi HA, Edward DP, et al. Pigmented hypopyon in association with Listeria monocytogenes endopthalmitis: An interesting case report following refractive surgery procedure with literature review. Middle East Afr J Ophthalmol. 2014;21(1):40–43. DOI:10.4103/0974-9233.124090
  • Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46(1):1–18.
  • Ballen PH, Loffredo FR, Painter B. Listeria endophthalmitis. Arch Ophthalmol (Chicago, Ill: 1960). 1979;97(1):101–102.
  • Domingos LC, Moreira MV, Keller KM, et al. Simultaneous quantification of gatifloxacin, moxifloxacin, and besifloxacin concentrations in cornea and aqueous humor by LC-QTOF/MS after topical ocular dosing. J Pharmacol Toxicol Methods. 2016. DOI:10.1016/j.vascn.2016.09.006
  • Belfort R, Jr., Gabriel L, Martins Bispo PJ, et al. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis. Adv Ther. 2012;29(5):416–426. DOI:10.1007/s12325-012-0018-8
  • Pawar PK, Katara R, Majumdar DK. Design and evaluation of moxifloxacin hydrochloride ocular inserts. Acta Pharm. 2012;62(1):93–104. DOI:10.2478/v10007-012-0002-5
  • Brasseur G, Retout A, Didier T, et al. [Listeria endophthalmitis: An uncommon etiology]. Bulletin des societes d’ophtalmologie de France. 1989;89(12):1463–1466.
  • Asena L, Akova YA, Goktas MT, et al. Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model. Curr Eye Res. 2013;38(4):472–479. DOI:10.3109/02713683.2012.763101
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535. DOI:10.1136/bmj.b2535
  • Duch ST, Quintana MC, Pujol OG. Listeria monocytogenes endophthalmitis. Acta Ophthalmol. 1991;69(1):108–110.
  • Bagnarello AG, Berlin AJ, Weinstein AJ, et al. Listeria monocytogenes endophthalmitis. Arch Ophthalmol (Chicago, Ill: 1960). 1977;95(6):1004–1005.
  • Dandagi PM, Belekar AM, Mastiholimath VS, et al. An improvement of the efficacy of moxifloxacin HCl for the treatment of bacterial keratitis by the formulation of ocular mucoadhesive microspheres. Sci Pharmaceut. 2013;81(1):259–280. DOI:10.3797/scipharm.1204-08
  • Grumbach NM, Mylonakis E, Wing EJ. Development of listerial meningitis during ciprofloxacin treatment. Clin Infect Dis. 1999;29(5):1340–1341. DOI:10.1086/313488
  • Cechova M, Fodor J, Halasova A, et al. [Listeria endophthalmitis]. Ceskoslovenska oftalmologie. 1980;36(4):256–259.
  • Abbott RL, Forster RK, Rebell G. Listeria monocytogenes endophthalmitis with a black hypopyon. Am J Ophthalmol. 1978;86(5):715–719.
  • Hueber A, Welsandt G, Grajewski RS, et al. Fulminant endogenous anterior uveitis due to Listeria monocytogenes. Case Rep Ophthalmol. 2010;1(2):63–65. DOI:10.1159/000321127
  • Weber AC, Levison AL, Srivastava SK, et al. A case of Listeria monocytogenes endophthalmitis with recurrent inflammation and novel management. J Ophthalmic Inflammation Infect. 2015;5(1):28. DOI:10.1186/s12348-015-0058-8
  • Online Post. Aldi pulls smoked salmon brand due to listeria concerns June 9 2015. 2015 Available at: http://cphpost.dk/news/aldi-pulls-a-brand-of-cold-smoked-salmon-after-listeria-is-found.html. Accessed January 18, 2017.
  • Barza M. Listeriosis and milk. N Engl J Med. 1985;312(7):438–440. DOI:10.1056/NEJM198502143120710
  • Maloney JM, Nolte FS, Meredith TA. Listeria monocytogenes endophthalmitis, treatment with vitrectomy and trimethoprim/sulfamethoxazole. Emory J Med. 1990;4(3):201–204.
  • Linnan MJ, Mascola L, Lou XD, et al. Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med. 1988;319(13):823–828. DOI:10.1056/NEJM198809293191303
  • Brian GR, Treplin MC. Listeria monocytogenes endophthalmitis: A case report. Aust N Z J Ophthalmol. 1988;16(4):329–331.
  • Schaftenaar E, Lecuona K, Baarsma S, et al. Anterior chamber paracentesis to improve diagnosis and treatment of infectious uveitis in South Africa. South Afr Med J. 2015;105(8):9552. DOI:10.7196/samj.9552
  • Cimino L. Unpublished case report. 2015.
  • Kleiner RC, Brucker AJ, Schweitzer JG, et al. Intraocular ampicillin in the treatment of endophthalmitis. Am J Ophthalmol. 1985;100(3):487–488.
  • Donnenfeld ED, Comstock TL, Proksch JW. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J Cataract Refractive Surg. 2011;37(6):1082–1089. DOI:10.1016/j.jcrs.2010.12.046
  • Proksch JW, Ward KW. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. J Ocul Pharmacol Ther. 2010;26(5):449–458. DOI:10.1089/jop.2010.0054
  • Westermeyer HD, Hendrix DV, Ward DA, et al. Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses. Am J Vet Res. 2011;72(3):398–403. DOI:10.2460/ajvr.72.3.398
  • Donnenfeld E, Perry HD, Chruscicki DA, et al. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability. Curr Med Res Opin. 2004;20(11):1753–1758. DOI:10.1185/030079904X5959
  • Callegan MC, Ramirez R, Kane ST, et al. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003;20(5):246–252.
  • Morvan A, Moubareck C, Leclercq A, et al. Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France. Antimicrob Agents Chemother. 2010;54(6):2728–2731. DOI:10.1128/AAC.01557-09
  • Granier SA, Moubareck C, Colaneri C, et al. Antimicrobial resistance of Listeria monocytogenes isolates from food and the environment in France over a 10-year period. Appl Environ Microbiol. 2011;77(8):2788–2790. DOI:10.1128/AEM.01381-10
  • Troxler R, von Graevenitz A, Funke G, et al. Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect. 2000;6(10):525–535.
  • Moreno LZ, Paixao R, Gobbi DD, et al. Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections. J Infect Dev Countries. 2014;8(4):416–423. DOI:10.3855/jidc.4188
  • Guerin F, Galimand M, Tuambilangana F, et al. Overexpression of the novel MATE fluoroquinolone efflux pump FepA in Listeria monocytogenes is driven by inactivation of its local repressor FepR. PLoS One. 2014;9(9):e106340. DOI:10.1371/journal.pone.0106340
  • Torkildsen G, Proksch JW, Shapiro A, et al. Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration. Clin Ophthalmol (Auckland, NZ). 2010;4:331–341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.